Depletion of regulatory T cells in HIV infection is associated with immune activation

被引:295
作者
Eggena, MP
Barugahare, B
Jones, N
Okello, M
Mutalya, S
Kityo, C
Mugyenyi, P
Cao, HY
机构
[1] Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA
[2] Joint Clin Res Ctr, Kampala, Uganda
关键词
D O I
10.4049/jimmunol.174.7.4407
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immune activation during chronic HIV infection is a strong clinical predictor of death and may mediate CD4(+) T cell depletion. Regulatory T cells (Tregs) are CD4(+)CD25(bright)CD62L(high) cells that actively down-regulate immune responses. We asked whether loss of Tregs during HIV infection mediates immune activation in a cross-sectional study of 81 HIV-positive Ugandan volunteers. We found that Treg number is strongly correlated with both CD4(+) and CD8(+) T cell activation. In multivariate modeling, this relationship between Treg depletion and CD4(+) T cell activation was stronger than any other clinical factor examined, including viral load and absolute CD4 count. Tregs appear to decline at different rates compared with other CD4(+) T cells, resulting in an increased regulator to helper ratio in many patients with advanced disease. We hypothesize that this skewing may contribute to T cell effector dysfunction. Our findings suggest Tregs are a major contributor to the immune activation observed during chronic HIV infection.
引用
收藏
页码:4407 / 4414
页数:8
相关论文
共 59 条
[1]   Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens [J].
Aandahl, EM ;
Michaëlsson, J ;
Moretto, WJ ;
Hecht, FA ;
Nixon, DF .
JOURNAL OF VIROLOGY, 2004, 78 (05) :2454-2459
[2]   Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: A worst-case dynamic analysis [J].
Anderson, RW ;
Ascher, MS ;
Sheppard, HW .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 17 (03) :245-252
[3]   CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 [J].
Annacker, O ;
Pimenta-Araujo, R ;
Burlen-Defranoux, O ;
Barbosa, TC ;
Cumano, A ;
Bandeira, A .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3008-3018
[4]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[5]   Human CD4+CD25+ regulatory T cells [J].
Baecher-Allan, C ;
Viglietta, V ;
Hafler, DA .
SEMINARS IN IMMUNOLOGY, 2004, 16 (02) :89-97
[6]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[7]  
BAECHERALLAN, 2003, NOVART FDN SYMP, V252, P67
[8]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[9]   Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses:: Relationship to viral load in untreated HIV infection [J].
Betts, MR ;
Ambrozak, DR ;
Douek, DC ;
Bonhoeffer, S ;
Brenchley, JM ;
Casazza, JP ;
Koup, RA ;
Picker, LJ .
JOURNAL OF VIROLOGY, 2001, 75 (24) :11983-11991
[10]   Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities [J].
Bisset, LR ;
Cone, RW ;
Huber, W ;
Battegay, M ;
Vernazza, PL ;
Weber, R ;
Grob, PJ ;
Opravil, M .
AIDS, 1998, 12 (16) :2115-2123